ACET Adicet Bio Inc. Net earnings per share growth forecast for next year
The assessment of forward net income growth rates for Adicet Bio (ACET) correlates with the development of universal cell products for oncology therapy, which expands the customer base. The value of 31.40 indicates the level of this metric. The high scientific reputation of top management guarantees the transparency of FDA data. However, reliance on patents in the absence of sales creates price volatility for the asset.
Analytical breakdowns for Adicet Bio, Inc. (ACET)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Adicet Bio|ACET - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Adicet Bio Inc.|ACET - Company Total Debt Obligations|Debts to Book Capitalization Adicet Bio|ACET - Company Long-Term Liabilities|Company Short-Term Debts Adicet Bio|Quick Liquidity Indicator adicetbio.com
- earnings and valuation multiples information:
ACET - Profit After Payment of Taxes|Future Profit Adicet Bio|ACET - Company Value to Net Income|Forward P/E Multiple Adicet Bio Inc.|ACET - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Adicet Bio|ACET - Operating income before deduction of amortization|Earnings per share for the last twelve months Adicet Bio|ACET - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth adicetbio.com|ACET - Earnings growth in current year|Earnings growth forecast for next year Adicet Bio
Initial company analysis:Adicet Bio, ACET
The efficiency of Adicet Bio (ACET) cryogenic drug logistics directly impacts future profitability, which is reflected in profit dynamics. This indicator measures the expected percentage growth of net earnings per share, allowing for an assessment of the business's fundamental stability and the risks of asset devaluation. By analyzing the current consensus EPS growth forecast for next year, an investor can determine the company's viability amidst market volatility.
Analysis of competing companies
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|GRFS - Earnings growth forecast for next year|ADPT: Earnings growth forecast for next year|Projected earnings per share growth rate for next year CLDX|AUPH (Aurinia Pharmaceuticals Inc.) - Earnings growth forecast for next year|BioCryst Pharmaceuticals, Inc. (BCRX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year VERA|Expected earnings per share growth for next year Dianthus Corp DNTH|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|abcellera.com (ABCL) - Expected net earnings per share growth next year|TRML: Expected earnings per share growth for next year|Precigen Inc - Projected earnings per share increase next year|PHAR (Pharming) - Expected earnings per share growth for next year|Nektar Corp - Expected earnings per share trend next year|UPB (Upstream Bio Inc) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year ZBIO|Earnings growth forecast for next year IMNM|Consensus forecast of earnings per share growth for next year Gossamer Bio Inc|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|Septerna Pharma (SEPN) - Expected net earnings per share growth next year|Pieris Pharmaceuticals - Earnings growth forecast for next year|SVRA - Earnings growth forecast for next year|RIGL: Earnings growth forecast for next year|Expected earnings per share growth for next year AnaptysBio Inc|ATXS (Astria Pharma) - Earnings growth forecast for next year|Expected net earnings per share growth next year enGene Corp ENGN|Expected earnings per share growth for next year RAPT (RAPT Therapeutics, Inc.)|Projected earnings per share increase next year JBIO|Net earnings per share growth forecast for next year Aclaris Therapeutics, Inc. ACRS|KYTX (Kyverna Therapeutics Inc.) - Net earnings per share change forecast for next year|Tiziana Life Sciences PLC - Earnings growth forecast for next year|Expected earnings per share trend next year CABA (Cabaletta Bio Inc)|VTYX: Earnings growth forecast for next year|theratech.com (THTX) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Avalo Therapeutics|ELDN: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Agenus Inc (AGEN)|Expected earnings per share growth for next year Climb Bio, Inc CLYM|Earnings growth forecast for next year ZURA (Zura Bio Limited)|Earnings growth forecast for next year atyrpharma.com ATYR|ADAG: Expected earnings per share growth for next year|Expected earnings per share trend next year IMA (ImageneBio Inc)|STTK: Earnings growth forecast for next year|EQ - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Connect Biopharma Holdings|Expected earnings per share growth for next year Immunic Inc (IMUX)|Net earnings per share growth forecast for next year Atara Biotherapeutics (ATRA)|Expected earnings per share growth for next year inflarx.de IFRX|X4 Pharma - Expected earnings per share growth for next year|Earnings growth forecast for next year Celularity Inc CELU|INMB - Net earnings per share growth forecast for next year|BRNS (barinthusbio.com) - Projected earnings per share growth rate for next year|KZR: Earnings growth forecast for next year|Expected net earnings per share growth next year SAB Biotherapeutics Inc. (SABS)|AKTX (Akari Therapeutics plc) - Earnings growth forecast for next year|Earnings growth forecast for next year Enlivex Therapeutics, Ltd.|Earnings growth forecast for next year QTTB|geovax.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year EDSA (Edesa Biotech)|Consensus forecast of earnings per share growth for next year iBio Inc (IBIO)|Carisma Tx - Earnings growth forecast for next year|XTL Bio (XTLB) - Expected earnings per share growth for next year|BOLT: Earnings growth forecast for next year|Expected net earnings per share growth next year HCW Biologics (HCWB)|Expected earnings per share growth for next year APVO|AIM (AIM ImmunoTech, Inc.) - Projected earnings per share increase next year|Expected earnings per share growth for next year ADTX (Aditxt)|GRI (GRI Bio Corporation) - Expected earnings per share trend next year|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc.)|reshapelifesciences.com - Net earnings per share growth forecast for next year|Revelation Biosciences, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Indaptus Therapeutics Inc INDP|Scinai (SCNI) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year CalciMedica (CALI)|AFMD (Affimed NV) - Earnings growth forecast for next year|Earnings growth forecast for next year Allakos Therapeutics|Earnings growth forecast for next year HOOK|Expected earnings per share growth for next year igmbio.com IGMS|Earnings growth forecast for next year ITOS (iTeos)|Ocean Biomedical Corp (OCEA) - Expected net earnings per share growth next year|TCBP: Expected earnings per share growth for next year|thirdharmonicbio.com - Projected earnings per share increase next year
